HK1120743A1 - 補骨脂酚的組合物及其製備方法 - Google Patents

補骨脂酚的組合物及其製備方法

Info

Publication number
HK1120743A1
HK1120743A1 HK09100162.3A HK09100162A HK1120743A1 HK 1120743 A1 HK1120743 A1 HK 1120743A1 HK 09100162 A HK09100162 A HK 09100162A HK 1120743 A1 HK1120743 A1 HK 1120743A1
Authority
HK
Hong Kong
Prior art keywords
bakuchiol
compositions
making
methods
same
Prior art date
Application number
HK09100162.3A
Other languages
English (en)
Inventor
賈琦
洪梅芬
Original Assignee
尤尼根公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 尤尼根公司 filed Critical 尤尼根公司
Publication of HK1120743A1 publication Critical patent/HK1120743A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
HK09100162.3A 2005-05-09 2009-01-07 補骨脂酚的組合物及其製備方法 HK1120743A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67933705P 2005-05-09 2005-05-09
PCT/US2006/018006 WO2006122160A2 (en) 2005-05-09 2006-05-09 Compositions of bakuchiol and methods of making the same

Publications (1)

Publication Number Publication Date
HK1120743A1 true HK1120743A1 (zh) 2009-04-09

Family

ID=37397255

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09100162.3A HK1120743A1 (zh) 2005-05-09 2009-01-07 補骨脂酚的組合物及其製備方法

Country Status (8)

Country Link
US (4) US20060251749A1 (zh)
EP (1) EP1881839A4 (zh)
JP (1) JP5443754B2 (zh)
KR (3) KR20130125411A (zh)
CN (1) CN101217968B (zh)
BR (1) BRPI0608796B8 (zh)
HK (1) HK1120743A1 (zh)
WO (1) WO2006122160A2 (zh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060251749A1 (en) 2005-05-09 2006-11-09 Unigen Pharmaceuticals, Inc. Compositions Of Bakuchiol And Methods Of Making The Same
CN101088498B (zh) * 2006-06-13 2011-09-07 和泓生物技术（上海）有限公司 补骨脂酚类化合物的应用
CN101224201B (zh) * 2007-01-18 2011-10-05 和泓生物技术（上海）有限公司 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用
US20080286217A1 (en) * 2007-05-14 2008-11-20 Chaudhuri Ratan K Sunscreen compositions and methods
ES2689715T3 (es) * 2007-05-14 2018-11-15 Sytheon Ltd. Composiciones para tratamiento de la piel y métodos
US8859021B2 (en) * 2007-05-14 2014-10-14 Sytheon Skin appearance through gene manipulation
US8529967B2 (en) * 2007-05-14 2013-09-10 Sytheon Ltd. Sunscreen compositions and methods
CN101406513B (zh) * 2008-12-03 2011-04-27 天津中医药大学 补骨脂提取物、含有它的药物组合物及其制备方法和用途
KR101144197B1 (ko) * 2009-03-31 2012-05-11 전남대학교산학협력단 신생혈관형성 억제제 및 이를 이용한 천연산물 항비만제
US20130261147A1 (en) * 2010-08-27 2013-10-03 Huazhong University Of Science & Technology Composition for preventing or treating dementia
DE102010062610A1 (de) * 2010-12-08 2012-06-14 Henkel Ag & Co. Kgaa Mund- und Zahnpflege- und -reinigungsmittel mit gesteigerter antibakterieller Wirkung I
DE102010062611A1 (de) * 2010-12-08 2012-06-14 Henkel Ag & Co. Kgaa Mund- und Zahnpflege- und -reinigungsmittel mit gesteigerter antibakterieller Wirkung II
US11253486B2 (en) * 2011-02-02 2022-02-22 Unigen, Inc. Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
WO2012106551A1 (en) * 2011-02-02 2012-08-09 Unigen, Inc. Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
WO2012105990A1 (en) * 2011-02-02 2012-08-09 Unigen, Inc. Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
FR2981275B1 (fr) * 2011-10-18 2015-03-20 Jean Noel Thorel Composition a base de meroterpene destinee aux peaux grasses, a tendance acneique ou atteintes d'acne
CN103857290A (zh) 2011-10-28 2014-06-11 金伯利-克拉克环球有限公司 包含氧化胺表面活性剂和氧化剂的混合物的杀芽孢制剂
BR112014010152A2 (pt) * 2011-10-28 2017-04-25 Kimberly Clark Co formulação esporicida e lenço
KR102002997B1 (ko) * 2011-11-03 2019-07-25 (주)아모레퍼시픽 탁시폴린 배당체를 유효성분으로 함유하는 화장료 조성물 및 작약 추출물의 추출방법
BE1020496A3 (fr) * 2012-02-10 2013-11-05 Ovogenics Sa Composition anti-inflammatoire pour moduler la reponse cellulaire des neutrophiles et des eosinophiles.
CN102875562B (zh) * 2012-07-27 2015-04-29 天津中医药大学 制备补骨脂素和异补骨脂素或包含它们的提取物的方法
WO2014167584A2 (en) * 2013-04-10 2014-10-16 Rupak Enterprises (P) Limited Herbal compositions for treating pain and skin disorders
JP2016522255A (ja) * 2013-06-19 2016-07-28 アクセス ビジネス グループ インターナショナル エルエルシーＡｃｃｅｓｓ Ｂｕｓｉｎｅｓｓ Ｇｒｏｕｐ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｌｃ 体重管理を支援するための植物をベースとしたケトヘキソキナーゼ阻害剤
KR101423005B1 (ko) * 2013-10-17 2014-07-28 강윤식 장 세정용 조성물
CN105267293B (zh) * 2014-07-24 2018-11-02 中国科学院大连化学物理研究所 补骨脂提取物或其单体成分制备人羧酸酯酶抑制剂的应用
CN105315295A (zh) * 2015-04-16 2016-02-10 霍秀菊 一种从补骨脂中分离纯化补骨脂素和异补骨脂素的方法
KR101725327B1 (ko) 2015-08-20 2017-04-10 숙명여자대학교 산학협력단 바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물
CN105061197A (zh) * 2015-08-28 2015-11-18 林天样 一种新的三萜化合物及其制备方法和医药用途
WO2017047769A1 (ja) * 2015-09-17 2017-03-23 国立大学法人富山大学 トール様受容体７またはトール様受容体９の活性化阻害剤
US11510885B2 (en) * 2019-12-02 2022-11-29 Sytheon Ltd. Compositions and methods for regulating the endocannabinoid system
KR102142464B1 (ko) * 2020-02-18 2020-08-10 (주)아모레퍼시픽 바쿠치올을 포함하는 피부 장벽 강화 또는 보습용 조성물
CN113041399A (zh) * 2021-03-19 2021-06-29 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 一种可缓释pso的杂化多层膜及其制备方法
CN115590848A (zh) * 2021-06-28 2023-01-13 上海中医药大学（Cn） 补骨脂有效成分治疗雄激素依赖性疾病的用途
NL2031273B1 (en) * 2022-03-04 2023-09-11 Sestina Bio Llc Bioproduction of bakuchiol
US20230340448A1 (en) * 2022-03-04 2023-10-26 Inscripta, Inc. Engineered enzymes and bioproduction of bakuchiol

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417234A (en) * 1962-06-21 1968-12-17 Svenska Dataregister Ab Record reading apparatus and method
US3553236A (en) * 1968-12-06 1971-01-05 Franco Indian Pharmaceuticals Psoralene and isopsoralene, process for their isolation and separation
DE1900435C3 (de) * 1969-01-04 1974-02-07 Franco-Indian Pharmacauticals Private Ltd., Bombay (Indien) Verfahren zur Isolierung und Trennung von Psoralen und Isopsoralen
DE3417234A1 (de) * 1984-05-10 1985-11-14 Rudolf V. Dr.rer.nat Dipl.-Chem. 5024 Pulheim Noronha Hautpflegemittel enthaltend eine kombination von bakuchiol und pyridinaldehyd
ZA954785B (en) * 1994-06-16 1996-02-08 Yamanouchi Pharma Co Ltd Crude drug-containing feed
US6054584A (en) * 1996-11-19 2000-04-25 The Board Of Regents Of The University And Community College System Of Neveda Process for extracting and purifying morphine from opium
JP3900388B2 (ja) 1997-08-28 2007-04-04 丸善製薬株式会社 美白剤および美白化粧料
KR20000007648A (ko) * 1998-07-06 2000-02-07 서경배 !보골지 추출물 및/또는 바쿠치올을 유효성분으로 하는 시클로옥시게나제-2 저해제 및 보골지추출물 및/또는 바쿠치올을 함유하는 항염증 화장료
FR2784294B1 (fr) 1998-10-12 2000-11-17 Oreal Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
JP2000327581A (ja) * 1999-05-19 2000-11-28 Higashimaru Shoyu Co Ltd 口腔殺菌用組成物
US6350476B1 (en) * 2000-05-22 2002-02-26 Shanxi Zhengzhon Pharmaceutical Co., Ltd. Herbal chinese joint complex
US6750248B2 (en) * 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
US20040043089A1 (en) * 2002-09-04 2004-03-04 Rabie A-Bakr M Buguzhi agent and composition and methods of preparing and administering the same
US7320797B2 (en) * 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
TWI298634B (en) * 2004-05-14 2008-07-11 Sinphar Pharmaceutical Co Ltd Pharmaceutical composition containing bakuchiol for treating woman osteoporosis
US20060251749A1 (en) 2005-05-09 2006-11-09 Unigen Pharmaceuticals, Inc. Compositions Of Bakuchiol And Methods Of Making The Same
US20080286217A1 (en) * 2007-05-14 2008-11-20 Chaudhuri Ratan K Sunscreen compositions and methods
ES2689715T3 (es) 2007-05-14 2018-11-15 Sytheon Ltd. Composiciones para tratamiento de la piel y métodos
US9676696B2 (en) * 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
WO2012106551A1 (en) * 2011-02-02 2012-08-09 Unigen, Inc. Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Also Published As

Publication number Publication date
KR101802415B1 (ko) 2017-11-28
US20060251749A1 (en) 2006-11-09
BRPI0608796B1 (pt) 2019-04-30
JP5443754B2 (ja) 2014-03-19
US20160022602A1 (en) 2016-01-28
EP1881839A4 (en) 2009-05-20
BRPI0608796A2 (pt) 2010-01-26
JP2008540551A (ja) 2008-11-20
KR20080016609A (ko) 2008-02-21
WO2006122160A3 (en) 2007-02-08
BRPI0608796B8 (pt) 2021-05-25
CN101217968A (zh) 2008-07-09
CN101217968B (zh) 2014-11-26
KR20160055972A (ko) 2016-05-18
US20110223267A1 (en) 2011-09-15
EP1881839A2 (en) 2008-01-30
WO2006122160A2 (en) 2006-11-16
KR20130125411A (ko) 2013-11-18
US10905654B2 (en) 2021-02-02
US20210154155A1 (en) 2021-05-27
KR101431060B1 (ko) 2014-08-21

Similar Documents

Publication Publication Date Title
EP1881839A4 (en) COMPOSITIONS FROM BACUCHIOL AND METHOD FOR THE PRODUCTION THEREOF
EP1879659A4 (en) REIZARING COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
EP1940423A4 (en) TISSUE ENGINEERING METHOD AND COMPOSITIONS
EP1895838A4 (en) COMPOSITIONS AND METHODS
EP1861341A4 (en) HYDRAULIC CEMENT COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF
ZA200802490B (en) Isoindole-imide compounds and compositions comprising and methods of using the same
ZA200808431B (en) Fungicidal compositions and methods of using the same
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
IL190885A0 (en) Immunogenic compositions and methods of use
GB0522287D0 (en) Method and compositions
IL191072A0 (en) Therapeutic compositions and methods
EP1968526A4 (en) FOAMING DENTAL COMPOSITIONS AND METHODS
PL2502983T3 (pl) Kompozycje na bazie Arthrospira i ich zastosowania
IL184834A0 (en) Compositions and methods for the manufacture thereof
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
EP1848438A4 (en) DIAMINOPHENOTHIAZINE COMPOSITIONS AND THEIR USE
EP1933805A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
GB0617171D0 (en) Novel compositions and methods
GB0524927D0 (en) Compositions and method
ZA200805711B (en) Solid biocidal compositions and methods of using the same
IL186337A0 (en) Stannsoporfin compositions and administration
IL186606A0 (en) Compositions and uses of amooranin compounds
GB0420356D0 (en) Detergent compositions and their manufacture
GB0501348D0 (en) Compositions and methods
GB0504657D0 (en) Compositions and methods of treatment